Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN\ROSUVASTATIN Cause Transient ischaemic attack? 25 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Transient ischaemic attack have been filed in association with ROSUVASTATIN\ROSUVASTATIN. This represents 4.5% of all adverse event reports for ROSUVASTATIN\ROSUVASTATIN.

25
Reports of Transient ischaemic attack with ROSUVASTATIN\ROSUVASTATIN
4.5%
of all ROSUVASTATIN\ROSUVASTATIN reports
0
Deaths
20
Hospitalizations

How Dangerous Is Transient ischaemic attack From ROSUVASTATIN\ROSUVASTATIN?

Of the 25 reports, 20 (80.0%) required hospitalization.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN\ROSUVASTATIN. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN\ROSUVASTATIN Cause?

Dyspnoea (79) Asthma (77) Pneumonia (52) Acute kidney injury (50) Wheezing (50) Myalgia (48) Drug hypersensitivity (46) Fatigue (44) Pain (44) Rhabdomyolysis (43)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which ROSUVASTATIN\ROSUVASTATIN Alternatives Have Lower Transient ischaemic attack Risk?

ROSUVASTATIN\ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN\ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN\ROSUVASTATIN vs ROXICODONE ROSUVASTATIN\ROSUVASTATIN vs ROXITHROMYCIN ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB

Related Pages

ROSUVASTATIN\ROSUVASTATIN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack ROSUVASTATIN\ROSUVASTATIN Demographics